-
EP4377360
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4377360
| EP4377360 - ANTI-CD3 ANTIBODIES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.05.2024 Database last updated on 02.09.2024 | |
| Former | The international publication has been made Status updated on 25.03.2023 | Most recent event Tooltip | 02.09.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Adimab, LLC 7 Lucent Drive Lebanon, NH 03766 / US | [2024/23] | Inventor(s) | 01 /
BATTLES, Michael, Benjamin Lebanon, New Hampshire 03766 / US | 02 /
LIU, Catherine, Yue Lebanon, New Hampshire 03766 / US | [2024/23] | Representative(s) | Page White Farrer Bedford House 21a John Street London WC1N 2BF / GB | [2024/23] | Application number, filing date | 22870965.5 | 16.09.2022 | [2024/23] | WO2022US76522 | Priority number, date | US202163245499P | 17.09.2021 Original published format: US 202163245499 P | [2024/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023044402 | Date: | 23.03.2023 | Language: | EN | [2023/12] | Type: | A1 Application with search report | No.: | EP4377360 | Date: | 05.06.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.03.2023 takes the place of the publication of the European patent application. | [2024/23] | Search report(s) | International search report - published on: | US | 23.03.2023 | Classification | IPC: | C07K16/28 | [2024/23] | CPC: |
C07K16/2809 (EP,IL,KR);
A61P29/00 (KR);
A61P31/00 (KR);
A61P35/00 (KR);
A61K2039/505 (KR);
A61K2039/545 (KR);
C07K2317/31 (EP,IL);
C07K2317/33 (EP,IL);
C07K2317/34 (EP,IL);
C07K2317/35 (EP,IL);
C07K2317/55 (EP,IL,KR);
C07K2317/56 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/23] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ANTI-CD3-ANTIKÖRPER | [2024/23] | English: | ANTI-CD3 ANTIBODIES | [2024/23] | French: | ANTICORPS ANTI-CD3 | [2024/23] | Entry into regional phase | 27.02.2024 | National basic fee paid | 27.02.2024 | Search fee paid | 27.02.2024 | Designation fee(s) paid | 27.02.2024 | Examination fee paid | Examination procedure | 27.02.2024 | Examination requested [2024/23] | Fees paid | Renewal fee | 02.09.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2019237081 (CULLINAN MAN INC [US]); | [A]WO2021034646 (IGM BIOSCIENCES INC [US]); | [XA]WO2021041250 (IGM BIOSCIENCES INC [US]) |